Burk Holdings’s Biogen BIIB Stock Holding History

Burk Holdings’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$4.11K	Hold	19	–	–	﹤0.01%	384
2026 Q1	$3.48K	Buy	+19	New	+$3.5K	﹤0.01%	420

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Burk Holdings's BIIB Position: Q2 2026 in Review

Burk Holdings held its Biogen (BIIB) position steady in Q2 2026 at 19 shares worth $4.11K. The position accounts for ﹤0.01% of the portfolio, ranked #384.

Burk Holdings first reported a position in BIIB in Q1 2026 and has held it in 2 quarters since. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Burk Holdings held 19 shares of Biogen worth $4.11K as of Q2 2026.
Burk Holdings left its Biogen share count unchanged in Q2 2026.
Biogen made up ﹤0.01% of Burk Holdings's portfolio in Q2 2026, its #384 holding.
Burk Holdings first reported a position in Biogen in Q1 2026 and has held it in 2 quarters since.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Burk Holdings's 13F filing for Q2 2026, filed 13 Aug 2026.